Pelicare Pharma Private Limited - Company Profile

It is a electrnoics private limited company based in Rajkot, Gujarat, India, established in 2018.
2018 Rajkot, Gujarat, India Struck Off
Last Updated:
Access Report
About Pelicare Pharma Private Limited

Pelicare Pharma Private Limited, a struck off private limited company, was established on 04 October 2018 in Rajkot, Gujarat, India. Engaging in repair services within the electrnoics sector, it holds CIN: U52609GJ2018PTC104569. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Bharat Jamnadas Shrimanker (Director), Suraj Ashvin Shah (Director), Pamee Ashvin Shah (Director). Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Pelican House, 6 - Kishanpara,, Rajkot, Gujarat, 360001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52609GJ2018PTC104569

  • Registration Number

    104569

  • Incorporation Date

    04 October 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 5 Months
  • Last Filing with ROC 31 Mar 2019
Company report

Pelicare Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pelicare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pelicare Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Bharat Jamnadas Shrimanker Director 04 Oct 2018 Current
Suraj Ashvin Shah Director 04 Oct 2018 Current
Pamee Ashvin Shah Director 04 Oct 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pelicare Pharma.

Enhance accessibility to Pelicare Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Pelicare Pharma revenue growth over time
Pelicare Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pelicare Pharma?

Unlock access to Pelicare Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pelicare Pharma?

Unlock and access historical data on people associated with Pelicare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pelicare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pelicare Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pelicare Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Pelicare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Pelicare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Ahmedabad. was documented.

  • Director Appointment

    Progress on Bharat Jamnadas Shrimanker was appointed as a Director was appointed as a Director on 04 Oct 2018 & has been associated with this company since 7 years 5 months . was documented.

  • Director Appointment

    Suraj Ashvin Shah was appointed as a Director was appointed as a Director on 04 Oct 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.

  • Director Appointment

    Progress on Pamee Ashvin Shah was appointed as a Director was appointed as a Director on 04 Oct 2018 & has been associated with this company since 7 years 5 months . was documented.

  • Company Incorporation

    Progress on Pelicare Pharma Private Limited was registered on 04 Oct 2018 with Roc Ahmedabad & aged 7 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pelicare Pharma Private Limited?

The CIN of Pelicare Pharma Private Limited is U52609GJ2018PTC104569.

Where is Pelicare Pharma Private Limited headquartered?

Pelicare Pharma Private Limited is headquartered at Pelican House, 6 - Kishanpara,, Rajkot, Gujarat, 360001.

When was Pelicare Pharma Private Limited incorporated?

Pelicare Pharma Private Limited was incorporated on 04 October 2018.

Who are the current directors of Pelicare Pharma Private Limited?

The current directors of Pelicare Pharma Private Limited are

What is the primary industry of Pelicare Pharma Private Limited?

The primary industry of Pelicare Pharma Private Limited is Electrnoics.

Is Pelicare Pharma Private Limited a listed company?

Pelicare Pharma Private Limited is unlisted.

What is the capital structure of Pelicare Pharma Private Limited?

The authorized capital of Pelicare Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available